Integrated conversion of plastic waste to high-value wax using nimos₂ catalysts
This technology offers an innovative catalytic process to convert polyolefin-rich plastic waste into high-value wax using NiMoS₂ catalysts, achieving 80-85% yields at lower temperatures than traditional methods. The process is cost-effective and impurity-tolerant, ideal for real-world waste streams.
Overview
This innovative process transforms polyolefin-rich plastic waste directly into high-value wax using a novel catalytic approach. Utilizing an earth-abundant NiMoS₂ catalyst, the process achieves high yields of 80-85% at temperatures significantly lower than conventional pyrolysis methods. The technology is designed for cost-effectiveness and enhanced selectivity, minimizing methane production and maximizing wax output. This solution is particularly suited for processing real-world, contaminated plastic waste streams.
Technical specifications
Key features:
- Operates at 250-300°C, reducing energy requirements compared to traditional pyrolysis
- Utilizes a slurry bubble column reactor for uniform heating and improved reaction kinetics
- Hydrogen co-feeding enhances selective hydroconversion with a total pressure over 55 bar
- NiMoS₂ catalyst provides high impurity tolerance and reduces the need for expensive catalysts like Ru or Pt
- Continuous operation capability with simultaneous reactive distillation for efficient wax separation
Technology readiness level
This technology is at TRL 4, indicating that it has been validated in a laboratory environment. The next steps involve feedstock characterization, quality control of the wax product, and scaling up the reactor for continuous operation trials. Collaborative studies for techno-economic analysis are invited to address commercialization hurdles.
About New York University
New York University is a comprehensive private research university anchored in New York City, enrolling a large, diverse student body and operating a global network of campuses. Corporate engagement is enabled by co‑located engineering and computing hubs in Brooklyn and Manhattan with shared labs and facilities for prototyping and field pilots. Integration with a major hospital system supports clinical translation, IRB processes, and access to real‑world data under stringent governance. Proximity to leading industries and a mature sponsored‑research function streamline scoping, NDAs, MSAs, and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DOD, and a dedicated technology transfer office manages IP, licensing, and startup creation.
Inquire about this partnering listing
Industry applications
delivered to your inbox.